Day: May 13, 2021

Strongbridge Biopharma plc Announces U.S. Food & Drug Administration (FDA) Filing Acceptance of New Drug Application (NDA) for RECORLEV® (levoketoconazole) for the Treatment of Endogenous Cushing’s Syndrome

epocrates and ConnectiveRx Announce Exclusive Reseller Partnership to Help More Patients Overcome Medication Cost Barriers with ScriptGuide Patient Savings Messages

Collaboration enables pharmaceutical companies to broaden their reach among healthcare prescribers and their patients WATERTOWN, Mass. & WHIPPANY, N.J.--(BUSINESS WIRE)--epocrates,...

error: Content is protected !!